Specialty code 1835P2201X · Vallejo, CA
NPI
1285391078
Since 2021
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
975 Sereno Dr
Vallejo, CA, 94589
Phone (707) 651-1000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$386K
2,426 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Catherine K Nang prescribed most often to Medicare patients was Atorvastatin Calcium, with 342 prescriptions and refills. In total Catherine K Nang wrote 2,426 Medicare prescriptions that cost $386K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 342 | 1,128 | 130 | $4,143 |
| Glipizide Er Glipizide | 298 | 966 | 104 | $11K |
| Metformin Hcl Er Metformin Hcl | 211 | 686 | 98 | $2,054 |
| Jardiance Empagliflozin | 175 | 506 | 62 | $84K |
| Humulin N Insulin Nph Human Isophane | 154 | 452 | 64 | $24K |
| Metformin Hcl Generic | 126 | 417 | 57 | $1,471 |
| Ozempic Semaglutide | 116 | 118 | 27 | $86K |
| Glipizide Generic | 98 | 327 | 45 | $1,324 |
| Lisinopril Generic | 72 | 240 | 32 | $877 |
| Simvastatin Generic | 69 | 230 | 28 | $812 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 65 | 195 | 30 | $1,534 |
| Losartan Potassium Generic | 61 | 203 | 31 | $729 |
| Amlodipine Besylate Generic | 52 | 168 | 33 | $648 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 50 | 137 | 24 | $981 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 49 | 126 | 18 | $8,716 |
Brand drugs: 727 claims; generic drugs: 1,517 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Catherine K Nang were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.